UB‐311, a novel UBITh <sup>®</sup> amyloid β peptide vaccine for mild Alzheimer's diseaseChang Yi Wang, Paul Frohna, Yuan‐Hung Tai et al.|Alzheimer s & Dementia Translational Research & Clinical Interventions|2017Cited by 142
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui Nimmo, James A. R. Nicoll, Jean‐Cosme Dodart et al.|Alzheimer s Research & Therapy|2020Cited by 48
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gutJacqui Nimmo, Roxana O. Carare, Jessica L. Teeling et al.|Acta Neuropathologica|2021Cited by 33
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide VaccineChang Yi Wang, T P Monath, Jian‐Jong Liang et al.|Research Square|2021Cited by 2
Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui Nimmo, James A. R. Nicoll, Jean‐Cosme Dodart et al.|Alzheimer s Research & Therapy|2023Cited by 2